AVTX - Avalo Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AVTX is currently covered by 2 analysts with an average price target of $3689.57. This is a potential upside of $3672 (20899.26%) from yesterday's end of day stock price of $17.57.

Avalo Therapeutics's activity chart (see below) currently has 8 price targets and 16 ratings on display. The stock rating distribution of AVTX is 33.33% HOLD and 66.67% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 2.5 days.

Highest price target for AVTX is $11, Lowest price target is $4.

Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 26-Jun-2023. First documented stock forecast 31-Mar-2019.

Best performing analysts who are covering AVTX - Avalo Therapeutics:

Chris Howerton Leland Gershell Gregory Renza Raghuram Selvaraju

Currently out of the existing stock ratings of AVTX, 1 are a HOLD (33.33%), 2 are a BUY (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$2400

2 years 4 months ago
(26-Jun-2023)

0/1 (0%)

$909.6 (61.03%)

Hold

$180

$162.43 (924.47%)

2 years 4 months 1 days ago
(25-Jun-2023)

0/2 (0%)

$60 (50.00%)

Hold

$720

$702.43 (3997.89%)

$2160

2 years 8 months 19 days ago
(07-Feb-2023)

2/3 (66.67%)

$-48 (-6.25%)

10

Buy

$31680

5 years 10 months 25 days ago
(01-Dec-2019)

0/1 (0%)

$13766.4 (76.85%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AVTX (Avalo Therapeutics) average time for price targets to be met?

On average it took 2.5 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on AVTX (Avalo Therapeutics) with a proven track record?

CHRIS HOWERTON

Which analyst has the current lower performing score on AVTX (Avalo Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on AVTX (Avalo Therapeutics)?

Chris Howerton has 0 price targets and 2 ratings on AVTX

Which analyst is the currently most bullish on AVTX (Avalo Therapeutics)?

Chris Howerton with highest potential upside - $702.43

Which analyst is the currently most reserved on AVTX (Avalo Therapeutics)?

Leland Gershell with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?